Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?

[...] high plasma HDL cholesterol and large HDL particles may be associated with increased CAD risk when levels of apoA-I and apoB remain constant. [...] liver X receptor agonists are also investigated as a possible measure of increasing reverse cholesterol transport and reversing atherosclerosis (4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2009-11, Vol.32 (11), p.S373-S377
Hauptverfasser:	Bitzur, Rafael, Cohen, Hofit, Kamari, Yehuda, Shaish, Aviv, Harats, Dror
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis Atherosclerosis - blood Atherosclerosis - epidemiology Atherosclerosis - mortality Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - blood Cardiovascular Diseases - epidemiology Cardiovascular Diseases - mortality Cholesterol Cholesterol, HDL Cholesterol, HDL - blood Cholesterol, LDL Complications and side effects Coronary Disease - blood Coronary Disease - epidemiology Coronary Disease - mortality Diabetes Diabetes Complications - blood Diabetes Complications - drug therapy Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - mortality Diabetic Angiopathies - blood Diabetic Angiopathies - drug therapy Dyslipidemias - blood Fatty Acids, Omega-3 - therapeutic use Health aspects Humans Hyperlipidemia Niacin - therapeutic use Obesity and Lipids PPAR alpha - agonists Risk factors Stroke - blood Stroke - epidemiology Stroke - mortality Triglycerides Triglycerides - blood Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...] high plasma HDL cholesterol and large HDL particles may be associated with increased CAD risk when levels of apoA-I and apoB remain constant. [...] liver X receptor agonists are also investigated as a possible measure of increasing reverse cholesterol transport and reversing atherosclerosis (47).
ISSN:	0149-5992 1935-5548
DOI:	10.2337/dc09-S343